TriangleGRALE (NCT01555892)
GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for Epstein-Barr virus positive lymphoma, Hodgkin or non-Hodgkin, that has come back or has not gone away after treatment.
The idea: train T cells to find the virus. EBV can be found in the cancer cells. T cells from the patient or a donor are grown in the lab to recognize EBV proteins, frozen, and later infused. Patients may first receive chemotherapy.
This phase 1 study tests safety at rising doses. At Baylor College of Medicine in Houston, Helen Heslop leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.